Physician profile
Omar Leonards
NPI 1295294486
$5,201.48
in general payments reported to CMS, 2019-2025
20 companies · $2,565 in 2025
The $2,565 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.01 · 2021: $13.15 · 2022: $168 · 2023: $874 · 2024: $1,570 · 2025: $2,565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,344 · Grant: $2,000 · Travel and Lodging: $390 · Education: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,343.96 |
| Grant | $2,000.00 |
| Travel and Lodging | $389.76 |
| Education | $274.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,000.00 | 2025 | |
| Penumbra, INC. | $742.31 | 2024 | Indigo System, Penumbra System |
| Shockwave Medical, INC | $542.06 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $315.96 | 2023-2025 | Lifevest |
| Abbott Laboratories | $297.54 | 2023-2025 | Mitraclip, Coroflow, Optis |
| Abiomed | $240.75 | 2024-2025 | Impella |
| Amgen INC. | $225.13 | 2023 | Repatha |
| Pfizer INC. | $206.71 | 2022-2023 | |
| Angiodynamics, INC. | $137.87 | 2025 | Alphavac, Auryon Laser System 100-120 Vac |
| Impulse Dynamics (USA) INC. | $112.33 | 2022 | |
| Itamar Medical INC | $103.73 | 2023 | Watchpatone |
| Stryker Corporation | $77.04 | 2025 | Flowtriever |
| Cardiovascular Systems INC. | $42.35 | 2023 | Diamondback Coronary |
| Astrazeneca Pharmaceuticals LP | $32.81 | 2022-2023 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $25.64 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $25.16 | 2019-2021 | |
| Atricure, INC. | $21.10 | 2023 | |
| Kestra Medical Technology Services, INC. | $20.29 | 2024 | Assure Wcd |
| Merck Sharp & Dohme LLC | $17.71 | 2023 | Verquvo |
| Janssen Pharmaceuticals, INC | $14.99 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Leonards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.